id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-P-0185-0006,FDA,FDA-2009-P-0185,"FDA/CDER to Bioniche Pharma, LLC. - Petition Approval",Other,PAV-Petition Approval,2010-10-07T04:00:00Z,2010,10,2010-10-07T04:00:00Z,,2013-08-11T03:11:09Z,,0,0,0900006480b6a607
FDA-2009-P-0185-0003,FDA,FDA-2009-P-0185,"Bioniche Pharma, LLC - Amendment",Other,AMD-Amendment,2009-12-16T05:00:00Z,2009,12,2009-12-16T05:00:00Z,,2013-07-27T23:01:53Z,,0,0,0900006480a6714d
FDA-2009-P-0185-0005,FDA,FDA-2009-P-0185,"Exhibit 2 - ""Pyridoxine Hydrochloride Injection, USP (Proposed Package Insert)"" - [Bioniche Pharma, LLC - Amendment ] re FDA-2009-P-0185-0003",Supporting & Related Material,AMD-(Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-16T19:17:31Z,,0,0,0900006480a67ba2
FDA-2009-P-0185-0004,FDA,FDA-2009-P-0185,"Exhibit 1 - ""Abraxis Pharmaceutical Products Labeling (Pyridoxine Hydrochloride)"" - [Bioniche Pharma, LLC - Amendment ] re FDA-2009-P-0185-0003",Supporting & Related Material,AMD-(Supporting and Related Material),2009-12-16T05:00:00Z,2009,12,,,2009-12-16T19:16:56Z,,0,0,0900006480a67ba0
FDA-2009-P-0185-0002,FDA,FDA-2009-P-0185,"Acknowledgement Letter to Bioniche Pharma, LLC.",Other,ACK-Acknowledgement Letter,2009-04-16T04:00:00Z,2009,4,2009-04-16T04:00:00Z,,2013-07-27T22:42:32Z,,0,0,0900006480953240
FDA-2009-P-0185-0001,FDA,FDA-2009-P-0185,"Bioniche Pharma, LLC. - Citizen Petition",Other,CP-Citizen Petition,2009-04-16T04:00:00Z,2009,4,2009-04-16T04:00:00Z,,2013-08-11T04:32:46Z,,0,0,0900006480952ff8